Results 31 to 40 of about 84,691 (282)
Hematologic malignancies comprise a diverse range of blood, bone marrow, and organ-related disorders that present significant challenges due to drug resistance, relapse, and treatment failure.
Ziyang Ding +6 more
doaj +1 more source
Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate [PDF]
: Fusariosis is due to inhalation or direct contact with conidia. Clinical presentation depends on host's immunity and can be localized, focally invasive or disseminated.
Marina Zoéga Hayashida +3 more
doaj +2 more sources
Mieloftisis como forma rara de presentación del carcinoma gástrico de células en anillo de sello
Myelophthisis refers to bone marrow invasion and displacement of hematopoietic tissue by elements such as neoplasms, fibrosis or granulomas. It is a rare but concerning finding in patients with non-hematologic malignancies.
Cristina Monteiro +3 more
doaj +1 more source
Anterior ischemic optic neuropathy and hematologic malignancy : a systematic review of case reports and case series [PDF]
© 2016 Canadian Ophthalmological SocietyObjective: Demographic and clinical characteristics associated with nonarteritic anterior ischemic optic neuropathy (NAION) are well described.
Pinto, Filomena +5 more
core +2 more sources
Thyroid tumors usually present as masses in the thyroid gland. While the majority of these tumors represent neoplasms of thyroid tissues, mainly of follicular epithelial cell differentiation, the differential diagnosis includes other lesions, such as C ...
Sylvia L. Asa +3 more
doaj +1 more source
Myelodysplastic/Myeloproliferative Neoplasms [PDF]
The myelodysplastic syndrome-myeloproliferative neoplasms (MDS/MPNs) are a heterogeneous group of hematologic malignancies characterized by dysplastic and myeloproliferative clinical, laboratory, and morphological overlapping features, both in marrow and
Yves Chalandon +2 more
core +1 more source
Differences between the oral changes presented by patients with solid and hematologic tumors during the chemotherapeutic treatment [PDF]
Objective: This study sought to identify the differences between the oral changes presented by patients with solid and hematologic tumors during chemotherapeutic treatment.
Isabella Lima Arrais Ribeiro +6 more
doaj +1 more source
The synchronous or metachronous coexistence of gastrointestinal stromal tumors (GISTs) with solid and hematologic neoplasms has been addressed in a non-transplant population.
Anna Mrzljak +4 more
doaj +1 more source
Immunotherapy in Hematologic Malignancies
The management of hematologic malignancies has traditionally relied on chemotherapy regimens, many of which are still in use today. However, with advancements in the knowledge of tumour pathophysiology, therapies are continually evolving.
C. Speziali, R.R. Kansara
core +1 more source
Secondary Neoplasm in Survivors of Childhood Hematological Malignancies—Systematic Review
Background: Childhood cancers account for approximately 1–2% of all malignancies worldwide, with hematologic cancers representing about 35–40% of pediatric cases.
Ioana-Alexandra Horneț +3 more
doaj +1 more source

